All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

502

Reset

502 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • AR-17043Phase 21 trial

    Alcon Research · Open Angle Glaucoma, Ocular Hypertension

  • ASP2246Phase 21 trial

    Astellas · Chronic Ischemic Stroke

  • AT673Phase 21 trial

    Antag Therapeutics · Adults With Overweight/Obesity and Type 2 Diabetes

  • ATR 1072Phase 21 trial

    Atrium Therapeutics · Cardiac Glycogenosis, Cardiomyopathy, Hypertrophic

  • AUP1602-CPhase 21 trial

    Aurealis Oy · Diabetic Foot Ulcer

  • AZD3427Phase 21 trial

    AstraZeneca · Pulmonary Hypertension (World Health Organization Group 2), Heart Failure

  • AZD5462Phase 21 trial

    AstraZeneca · Chronic Heart Failure

  • B2065Phase 21 trial

    Tasly Pharmaceutical Group Co., Ltd · Acute Ischemic Stroke

  • BAY 3670549Phase 21 trial

    Bayer · Atrial Fibrillation

  • BAY3018250Phase 21 trial

    Bayer · Thrombolysis, Symptomatic Proximal Deep Vein Thrombosis

  • BB-031DTRI-031Phase 21 trial

    Basking Biosciences, Inc. · Acute Ischemic Stroke

  • BB-101Phase 21 trial

    Blue Blood Biotech Corp. · Diabetic Foot Ulcer

  • BEBT-701Phase 21 trial

    BeBetter Med Inc · Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol

  • BGM1812plcaeboPhase 21 trial

    BrightGene Bio-Medical Technology Co., Ltd. · Overweight or Obese Participants Without Diabetes

  • BI 3034701Phase 21 trial

    Boehringer Ingelheim · Obesity, Overweight

  • BI 3812465Phase 21 trial

    Boehringer Ingelheim · Diabetic Macular Edema

  • BI 764524Phase 21 trial

    Boehringer Ingelheim · Diabetic Retinopathy

  • BIO101Phase 21 trial

    Biophytis · Muscle Wasting, Obesity & Overweight, Obesity

  • BMS-986435MYK-224Phase 21 trial

    Bristol Myers Squibb · Heart Failure

  • BR1400-1Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BR1400-2Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BR1400-3Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BR1400-4Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BR1400-5Phase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BR1400-APhase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BR1400-BPhase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BR1400-CPhase 21 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension

  • BW-00112Phase 21 trial

    Shanghai Argo Biopharmaceutical Co., Ltd. · Mixed Dyslipidemia

  • CD25Phase 21 trial

    PolTREG S.A. · Presymptomatic Diabetes Type 1 (Stage 1), Diabetes Mellitus, Type I, Diabetes Mellitus, Type 1

  • CNP-103Phase 21 trial

    COUR Pharmaceutical Development Company, Inc. · Type 1 Diabetes Mellitus, T1D, T1DM

  • COR-1167Phase 21 trial

    Corteria Pharmaceuticals · Worsening Heart Failure

  • CPX101Phase 21 trial

    Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd. · Overweight and Obesity

  • CTX340Phase 21 trial

    CRISPR Therapeutics AG · Hypertension

  • CU01-1001Phase 21 trial

    Curacle Co., Ltd. · Diabetic Nephropathies

  • CU06-1004Phase 21 trial

    Curacle Co., Ltd. · DME, Diabetic Macular Edema, Diabetic Macular Edema (DME)

  • DA-2811Phase 21 trial

    Dong-A ST Co., Ltd. · Diabete Mellitus

  • DA-2811-CPhase 21 trial

    Dong-A ST Co., Ltd. · Diabete Mellitus

  • DIAG723Phase 21 trial

    Diagonal Therapeutics, Inc. · Hereditary Hemorrhagic Telangiectasia, Pulmonary Arterial Hypertension

  • DNV001Phase 21 trial

    Hangzhou Dinovate Biotech Co., Ltd · Primary Hypercholesterolemia

  • EDG-15400Phase 21 trial

    Edgewise Therapeutics, Inc. · Heart Failure With Preserved Ejection Fraction

  • EDG-7500Phase 21 trial

    Edgewise Therapeutics, Inc. · Hypertrophic Cardiomyopathy

  • EDIT-401Phase 21 trial

    Editas Medicine, Inc. · Heterozygous Familial Hypercholesterolemia (HeFH)

  • ELU42Phase 21 trial

    Eluciderm Inc · Diabetic Foot Ulcer, Wagner Grade 1 - 2, Chronic Wound

  • ENN0403Phase 21 trial

    EnnovaBio · Diabetic Macular Edema (DME)

  • ERX1000Phase 21 trial

    ERX Pharmaceuticals · Obesity & Overweight

  • GL0034Phase 21 trial

    Sun Pharmaceutical Industries Limited · Type II Diabetes Mellitus

  • GZR101-80Phase 21 trial

    Gan & Lee Pharmaceuticals. · Type 2 Diabetes (T2DM)

  • GZR102Phase 21 trial

    Gan & Lee Pharmaceuticals. · Type 2 Diabetes Mellitus (T2DM)

  • HBI-3000sulcardine sulfatePhase 21 trial

    HUYABIO International, LLC. · Atrial Fibrillation

  • HD-6277Phase 21 trial

    Hyundai Pharm · Type 2 Diabetes Mellitus (T2DM)

NewerPage 8 of 11Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.